Whole brain free fatty acids (FFA) continue to rise appreciably even I h after decapitation, which may reflect the evolution of ischemic brain injury at least during global ischemia, If so, the attenuation of FFA liberation by various drugs may reflect their efficacy in ischemic brain injury. Rats were pretreated with either 0.9% NaCI (controls), ketamine, halothane, lofentanil, etomidate, Y-9179, R41-468, Innovar-Vert', pentobarbital, thiopental, or phe nytoin and decapitated 15 to 30 min thereafter. The brains were kept nor mothermic for 10 min until they were frozen in liquid nitrogen. Whole brain FFAs were quantitated by gas-liquid chromatography. After 10 min of ische mia in controls, total FFAs and arachidonic, stearic, oleic, and palmitic acids increased by 8-to lO-fold. The drugs, in order of decreasing effectiveness in attenuating FFA liberation, fell into the following three groups: (1) phenytoin, thiopental, pentobarbital, and Innovar-Vet; (2) R41-468, Y-9179, and etomi date; and (3) lofentanil, halothane and ketamine. The three groups reduced total FFAs by about 23%, 13%, and 8%, respectively. The effectiveness of the drugs in attenuating FF A liberation appears to correlate with their efficacy in ischemic brain injury. However, a cause and effect relationship between FFA liberation and the evolution of ischemic brain injury must be established before accurate predictions of efficacy can be made by this method. The limitations of the proposed method of evaluation are discussed.
. However. all things being equal, it correlates directly, but not necessarily linearly, with the duration of ischemia. Indeed, the apparent "threshold" of severe permanent brain damage oc curs after ischemia of 15 min or longer (Miller and Myers, 1970; Wolin et aI.. 1971; Nemoto et aI., 1977) . However, it may be a function of the sen sitivity of the neurologic examination rather than a true reflection of the evolution of brain damage.
Despite the apparent correlation between dura tion of ischemia and severity of damage, attempts to relate the time course of changes in cerebral meta bolic and physiologic variables during ischemia with its duration have been fruitless. The electroenceph alogram (EEG) is isoelectric 10 to 15 s after com plete cessation of brain circulation (Wolin et aI., 1971; N emoto et aI., 1977) . Brain high-energy phos phates, glucose, and lactate reach plateau levels within 5 min and thereafter remain relatively un changed even after 20 min of ischemia (Lowry et aI., 1964; Michenfelder and Theye, 1970 ). Yet, S min of ischemia does not cause maximum brain damage, suggesting that further biochemical changes must occur. The sum of adenine nucleo tides and tissue ammonia continues to change even after 15 min of ischemia (Ljunggren et aI., 1974) , but the changes are not unlike the continued slow de cline in adenosine triphosphate (A TP) between 5 and 15 min of ischemia (Lowry et aI., 1964) . Bazan (1970) and Bazan et aI. (1971) reported that brain free fatty acids (FF A) increase rapidly during the first 4 to 5 min after decapitation, but plateau between 10 and 30 min. However, the brains were left at room temperature after decapitation, which probably reduced the rate of FF A accumulation with time. We repeated their studies, but kept the brains at 37°C, and found a more sustained and nearly linear rise in FF A even after 1 h of ischemia (Shiu and Nemoto, 1981; Shiu et aI., 1982) . We suggested that it may be related to the evolution of ischemic brain injury. We also suggested that the degree of FF A attenuation by various drugs may reflect their potential efficacy in ischemic brain damage. Based on this rationale, we now attempt to determine if the degree of FF A attenuation during ischemia by various drugs correlates with the drugs' reported efficacies.
METHODS AND MATERIALS
Female, Sprague-Dawley rats weighing 350 to 500 g were laboratory acclimatized and had free access to food and water up until the time of the studies. They were pretreated with the various drugs and decapitated 15 or 30 min later (Table 1) . Control rats were injected in traperitoneally with 4 ml 0.9% NaCI 15 min before de capitation. Rats exposed to 1% halothane were placed into a 5-L chamber insufflated with 1 % halothane in O2 for 15 min before decapitation. In earlier studies (unpub lished observations), we found that arterial pressures, blood gases, pH, and rectal temperatures were within normal limits in rats treated with 1% halothane, Innovar-Vet, pentobarbital, and thiopental, as described in Table 1 . Rats treated with the other drugs were som nolent, at worst, but could be aroused.
After decapitation, the rats' heads were sealed in plas tic bags containing saline-soaked sponges in an incubator at 37°C. At 9.5 min postdecapitation, the brains were re- moved from the calvaria and dropped into liquid N2 at exactly 10 min. For FF A levels after 0.5 min of ischemia, the brains were quickly removed from the calvaria and dropped into liquid N2 immediately after decapitation. We previously described the methods for determination of whole brain FFA (Shiu and Nemoto, 1981) . However, the thin-layer chromatography (TLC) procedures were recently modified (Shiu et aI., 1982) because with the pre vious method some of the FFAs, but not arachidonic acid, may have been derived from tri-and diglycerides during the methyl esterfication step. The data reported in this study were obtained using the modified TLC proce dures.
Briefly, the frozen brains were weighed and whole brain lipids extracted in N2 gas-equilibrated chloro form: methanol (2: 1, vol/vol) (Folch et aI., 1957) . The FF As were separated by TLC along with FF A standards for palmitic, oleic, stearic, and arachidonic acids on silica gel G plates and developed with heptane:anhydrous diethyl ether:glacial acetic acid (70:30: 1.5, vol/vol/vol), a modification of the methods described by Snyder and Blank (1968) . The silica gel extract was redissolved in 6 ml benzene:methanol:lO N sulfuric acid (123:61:1, vol/ vol/vol) and methyl esterfied by heating to 60°C for 2 h (Morin et aI., 1962) . FFA methyl esters were reconsti tuted in 100 iLl heptane with 46.8 nmol methyl hep tadecanoate (17:0) for calibration of the volume injected into the gas chromatograph. Arachidonic, stearic, palmi tic, oleic, and linoleic acids were quantitated by gas-liquid chromatography. Peak areas were integrated by a Shimaduz CRIA microprocessor. FFAs are ex pressed in nmoles per gram of fresh brain corrected for percent recovery (see below) determined by nonadecanoic acid (19:0). Total FFA was calculated as the sum of arachidonic, stearic, palmitic, oleic, and linoleic acids.
Prior to homogenization of the frozen brains in chloro form: methanol, 160 nmol nonadecanoic acid was added as an internal standard to estimate percent recovery. The overall percent recovery in 170 determinations was 42. 5 ± 7. 5% (±SD). Percent recovery tests were also done in separate experiments with 14C-labeled FF As and nonadecanoic acid. 14C_ FF A percent recovery was higher than that for nonadecanoic acid. The 14C-FFA values do not account for loss in the methyl esterfication step.
One-microliter samples were assayed in triplicate on a Varian model 3700 gas-liquid chromatograph using a glass coiled column with 10% SP-2330 on 100/120 mesh chromosorb W-AW. The injector, detector, and oven temperature were set at 280, 300, and 180aC, respectively. Gas flow rates were Nz, 12 mllmin; Hz, 30 mllmin; and air, 300 mllmin. FF A concentrations were calculated as fol lows:
Fractional recovery x brain wt (g) where, C is the concentration of FFA in the final recon stituted heptane solution and V is volume of the heptane used for final reconstitution (100 p,l).
All statistical comparisons were made by standard un paired t tests with a maximum significant p value of 0.05.
RESULTS
Total FFA in whole brain after 0.5 min of isch emia was 290 ± 30 nmollg brain (±SEM) and in creased threefold after 10 min of decapitation isch emia to 899 ± 19 nmollg brain ( Fig. 1 ). It was sig nificantly attenuated by all drugs including ketamine. Phenytoin, followed by thiopental, pentobarbital, and Innovar-Vet were most effective, reducing total FFA by about 23% to 695 ± 29 nmollg brain. R41-468, Y-9179, and etomidate decreased total FFA by 12 to 14%, and lofentanil, halothane, and ketamine decreased it by 7 to 9%. Thus, in terms of attenuation of total FF A accumulation, the drugs could be grouped in order of decreasing effective ness: (1) phenytoin, thiopental, pentobarbital, and Innovar-Vet; (2) R41-468, Y-9179, and etomidate; and (3) lofentanil, halothane, and ketamine.
Arachidonic acid (20:4) rose from 44 ± 15 nmollg brain after 0.5 min of ischemia to about 260 nmollg brain after 10 min of ischemia. It was not affected by ketamine or etomidate (Fig. 2) . The greatest de gree of attenuation was by phenytoin, thiopental, and pentobarbital, which reduced arachidonic acid Whole brain total free fatty acids (FFA) (nmol/g brain) in rats after 10 min normothermic decapitation ischemia fol lowing treatment with various drugs. Total FFA = sum of palmitic (16:0), oleic (18:1), stearic (18:0), linoleic (18:2), and arachidonic (20:4) acids. The rats were treated with the vari ous drugs (see Table 1 ), decapitated, and the heads incubated at 3TC before freezing in liquid N2• Shaded bar shows total FFA level after 0.5 min of ischemia. Numbers in paren theses indicate number of rats studied for each drug. Com pared to NaCI control: (*) p < 0.05, (**) P < 0.02, (+) P < 0.01, (+ +) p < 0.001. Error bars indicate SEM.
liberation by about 20% from 260 to 210 nmollg brain, whereas Innovar-Vet was slightly less effec tive, reducing it by about 15%. All of the other drugs except for ketamine were equally effective, causing an 8% reduction. The threefold increase in stearic acid (18:0) liber ation between 0.5 and 10 min of ischemia was unaf fected by ketamine, halothane, or lofentanil (Fig.  2) -the least effective group of drugs. All the other drugs reduced stearic acid accumulation in the same general order as they did for total FF A except that thiopental did not appear to be as effective as pen tobarbital or phenytoin.
As observed for total FF A, all the drugs tested significantly attenuated palmitic and oleic (Fig. 2 ) acid accumulation. Palmitic acid (16:0) increased from 68 ± 10 to 185 ± 5 nmollg brain between 0.5 and 10 min of ischemia. Although the accumulation of this acid was significantly attenuated by all drugs, the effects of ketamine, halothane, and lofentanil appeared to be less when compared to the effects of the other two groups of drugs. Oleic acid (18: 1) in creased from 69 ± 10 to 139 ± 5 nmollg brain be tween 0.5 and 10 min of ischemia. Again, there ap pears to be a step-wise effect of the three groups of drugs in attenuating the accumulation of this acid.
DISCUSSION
Our results show that the drugs tested for at tenuating brain FF A liberation during ischemia fell Whole brain arachidonic, stearic, palmitic, and oleic acids (nmol/g brain) after 10 min decapitation ischemia in rats treated with various drugs (see Table 1 ). Shaded bars indicate the level of each of the FFAs in whole brain after 0.5 min of ische mia. See Fig. 1 legend for other details. into the following three groups in order of decreas ing effectiveness: (1) phenytoin, thiopental, pen tobarbital, and Innovar-Vet;
(2) R41-468, Y-9179, and etomidate; and (3) lofentanil, halothane, and ketamine. We emphasize that our hypothesis-that FF A liberation during global ischemia is related to the evolution of ischemic brain injury and that the attenuation of FF A liberation by various drugs is related to their efficacy in preventing ischemic brain injury-is presently highly speculative. However, as we have previously discussed (Shiu and Nemoto, 1981) , there is substantial evidence indicating that FF A liberation is relevant to the evolution of isch emic brain injury. Our findings now suggest that there does appear to be a general correlation tween the effectiveness of drugs in attenuating ische mic brain injury and FF A liberation during ischemia. Barbiturates such as pentobarbital and thiopental have been intensively studied in brain protection. In animal models of focal brain ischemia, they have been consistently effective in attenuating ischemic brain injury (Yatsu et aI., 1972; Smith et aI., 1974; Hoff et aI., 1975; Mosely et aI., 1975; Michenfelder et aI., 1976; Lightfoote et aI., 1977; Black et aI., 1978; Corkill et aI., 1978; Levy and Brierley, 1979) . No.4. 1982 However, their effectiveness in models of global brain ischemia is still controversial. Although Wright and Ames (1964) and Goldstein et al. (1966) reported that barbiturates improved recovery when administered before ischemia, and Bleyaert et ai. (1978) reported thiopental was effective when ad ministered postinsult, these findings were not sup ported in studies by Steen et ai. (1979) or Snyder et ai. (1979) . Steen et al. attempted to reproduce the studies by Goldstein et al. (1966) , but used N20 anesthesia during the preparation of the control dogs, which reduced the severity of damage sus tained and nullified the difference between the con trol and pentobarbital groups. Severe arterial hypotension was allowed to occur during thiopental administration in the studies by Snyder et ai. (1979) . Thus, the weight of the evidence indicates that bar biturates are effective in the treatment of ischemic brain injury.
Although not as intensively studied as the bar biturates, phenytoin was reported to be effective, and more effective than thiopental, by Aldrete et al. (1979) and Cullen et ai. (1979) . In an uncontrolled clinical trial (Aldrete et aI., 1981) promising results with phenytoin were also reported in patients after cardiac arrest. Innovar-Vet has not been tested for its ability to attenuate ischemic brain injury. How ever, it has been tested because of its apparent effi cacy in attenuating freeze-injury induced brain edema in dogs (Smith and Marque, 1976) , which was similar to that of the barbiturates. It is likely that the effectiveness of Innovar-Vet resides in the droperidol component, since lofentanil, which is related to fentanyl, was not as effective. Further more, the findings of Parmentier et al. (1976) with sufentanil, a related drug, were unimpressive even at large doses.
Based on the attenuation of FF A liberation, the second group of drugs-namely, R41-468, Y-9179, and etomidate-were less effective than those dis cussed above. R41-468, an S2 serotonin receptor blocker, has not been previously tested for effec tiveness in ameliorating ischemic brain injury, but was studied because of the possible involvement of serotonin in aggravating ischemic brain damage (Welch et al. , 1977) . It appears to be as effective as Y-9179, which has been shown to improve the tol erance of mice to anoxia (Yasuda et al. , 1978) and in focal cerebral ischemia (Tamura et aI. , 1979) . Al though our results suggest that etomidate is less ef fective than the barbiturates, Wauquier et al. (1981) reported that according to the ED50 values, etomi date was more effective than thiopental and methohexital in gasping, hypobaric-hypoxia, and histotoxic-anoxic tests in rats. Our results con tradict these findings, but the relevance or validity of the tests they used is questionable, since the car diovascular and respiratory depressant effects of the barbiturates could influence the results without any direct relationship to the efficacy of the drugs in ameliorating ischemic brain damage.
The effectiveness of ketamine per se has not been tested in ischemic brain injury, but Moseley et aI. (1975) used controls anesthetized with ketamine to evaluate the effectiveness of barbiturates in at tenuating focal ischemic brain injury, and reported a significant effect with barbiturates compared to ketamine. Thus, we can at least say that ketamine is not as effective as barbiturates. Halothane was as ineffective as ketamine in attenuating FF A libera tion, which supports the findings of Smith et al. (1974) , who reported it ineffective in focal ischemic brain injury in dogs. Indeed, it even appeared to worsen neurologic outcome. Lofentanil has not been previously evaluated for amelioration of isch emic brain injury, but a related drug, sufentanil, has been found to be ineffective in massive doses (Par mentier et al. , 1976) . In general, our findings on the ability of the various drugs to attenuate FF A libera tion correlate with their reported efficacies in the treatment of ischemic brain injury. However, this study has merely shown a general correlation rather than a cause and effect relationship. The accurate evaluation of drugs for potential efficacy must await clarification of the precise relationship between FF A accumulation and the process of ischemic brain injury.
The limitations of the proposed screening method must be recognized. First, in this model, drugs and procedures can be evaluated only with pretreat ment, as opposed to the more clinically relevant postinsult treatment. Second, only those drugs act ing on metabolic events that occur during ischemia, which may or may not be relevant to postinsult pro cesses, can be evaluated. However, metabolic changes occurring during ischemia probably con tribute to postinsuIt physiologic and metabolic changes. For example, the rise in arachidonic acid may be important in delayed postischemic hypo perfusion, which is prevented by indomethacin pretreatment (Hallenback and Furlow, 1979) . Fi nally, those drugs or procedures effective in physi cally rather than metabolically improving circula tion cannot be evaluated.
